KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.
KuriBio has raised $150K in total funding. The most recent round was Grant. The last funding was announced in September 2024.
KuriBio is headquartered in Berkeley, United States.
KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.
KuriBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KuriBio — Funding & Investors." VCBacked, September 8, 2024, https://www.vcbacked.co/company/kuribio. Accessed August 13, 2026.
VCBacked. (2024). KuriBio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/kuribio
{{cite web |title=KuriBio — Funding & Investors |url=https://www.vcbacked.co/company/kuribio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated